Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Tan

Showing results (461-470 of 505) with videos related to

Pageof 51
Sort By:
Journal of the National Cancer Institute. Monographs|February 24, 2025
Intracluster correlation coefficients from cluster randomized trials conducted within the NCI Community Oncology Research Program (NCORP)Anna C Snavely, Heather J Gunn, Ju-Whei Lee, et al.
Alimentary Pharmacology & Therapeutics|March 10, 2018
Responses are durable for up to 5 years after completion of peginterferon alfa-2a treatment in hepatitis B e antigen-positive patientsW-L Chuang, J Jia, H L Y Chan, et al.
Plos One|July 24, 2019
AGT haplotype in ITGA4 gene is related to antibody-mediated rejection in heart transplant patientsLucía Núñez, Grecia M Marrón-Liñares, María G Crespo-Leiro, et al.
Plos Medicine|November 23, 2013
A brief Patient-Reported Outcomes Quality of Life (PROQOL) instrument to improve patient careJennifer L Ridgeway, Timothy J Beebe, Christopher G Chute, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 13, 2019
A Randomized Double-Blind Phase II Study of the Seneca Valley Virus (NTX-010) versus Placebo for Patients with Extensive-Stage SCLC (ES SCLC) Who Were Stable or Responding after at Least Four Cycles of Platinum-Based Chemotherapy: North Central Cancer Treatment Group (Alliance) N0923 StudyErin L Schenk, Sumithra J Mandrekar, Grace K Dy, et al.
JAMA|April 17, 2019
Effect of Doxepin Mouthwash or Diphenhydramine-Lidocaine-Antacid Mouthwash vs Placebo on Radiotherapy-Related Oral Mucositis Pain: The Alliance A221304 Randomized Clinical TrialTerence T Sio, Jennifer G Le-Rademacher, James L Leenstra, et al.
Journal of Healthcare Leadership|March 4, 2024
Navigating the Healthcare Conundrum: Leadership Perspective from a Premier Healthcare Organization in Loma Linda's Blue ZoneLaren D Tan, Anthony A Hilliard, Ricardo L Peverini, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 2, 2014
Impact of brachytherapy on local recurrence rates after sublobar resection: results from ACOSOG Z4032 (Alliance), a phase III randomized trial for high-risk operable non-small-cell lung cancerHiran C Fernando, Rodney J Landreneau, Sumithra J Mandrekar, et al.
The Journal of Thoracic and Cardiovascular Surgery|December 16, 2014
Analysis of longitudinal quality-of-life data in high-risk operable patients with lung cancer: results from the ACOSOG Z4032 (Alliance) multicenter randomized trialHiran C Fernando, Rodney J Landreneau, Sumithra J Mandrekar, et al.
Science Advances|September 6, 2023
Lignin conversion to β-ketoadipic acid by <i>Pseudomonas putida</i> via metabolic engineering and bioprocess developmentAllison Z Werner, William T Cordell, Ciaran W Lahive, et al.
Pageof 51

Showing results (461-470 of 505) with videos related to

Sort By:
Pageof 51
Journal of the National Cancer Institute. Monographs|February 24, 2025
Intracluster correlation coefficients from cluster randomized trials conducted within the NCI Community Oncology Research Program (NCORP)Anna C Snavely, Heather J Gunn, Ju-Whei Lee, et al.
Alimentary Pharmacology & Therapeutics|March 10, 2018
Responses are durable for up to 5 years after completion of peginterferon alfa-2a treatment in hepatitis B e antigen-positive patientsW-L Chuang, J Jia, H L Y Chan, et al.
Plos One|July 24, 2019
AGT haplotype in ITGA4 gene is related to antibody-mediated rejection in heart transplant patientsLucía Núñez, Grecia M Marrón-Liñares, María G Crespo-Leiro, et al.
Plos Medicine|November 23, 2013
A brief Patient-Reported Outcomes Quality of Life (PROQOL) instrument to improve patient careJennifer L Ridgeway, Timothy J Beebe, Christopher G Chute, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 13, 2019
A Randomized Double-Blind Phase II Study of the Seneca Valley Virus (NTX-010) versus Placebo for Patients with Extensive-Stage SCLC (ES SCLC) Who Were Stable or Responding after at Least Four Cycles of Platinum-Based Chemotherapy: North Central Cancer Treatment Group (Alliance) N0923 StudyErin L Schenk, Sumithra J Mandrekar, Grace K Dy, et al.
JAMA|April 17, 2019
Effect of Doxepin Mouthwash or Diphenhydramine-Lidocaine-Antacid Mouthwash vs Placebo on Radiotherapy-Related Oral Mucositis Pain: The Alliance A221304 Randomized Clinical TrialTerence T Sio, Jennifer G Le-Rademacher, James L Leenstra, et al.
Journal of Healthcare Leadership|March 4, 2024
Navigating the Healthcare Conundrum: Leadership Perspective from a Premier Healthcare Organization in Loma Linda's Blue ZoneLaren D Tan, Anthony A Hilliard, Ricardo L Peverini, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 2, 2014
Impact of brachytherapy on local recurrence rates after sublobar resection: results from ACOSOG Z4032 (Alliance), a phase III randomized trial for high-risk operable non-small-cell lung cancerHiran C Fernando, Rodney J Landreneau, Sumithra J Mandrekar, et al.
The Journal of Thoracic and Cardiovascular Surgery|December 16, 2014
Analysis of longitudinal quality-of-life data in high-risk operable patients with lung cancer: results from the ACOSOG Z4032 (Alliance) multicenter randomized trialHiran C Fernando, Rodney J Landreneau, Sumithra J Mandrekar, et al.
Science Advances|September 6, 2023
Lignin conversion to β-ketoadipic acid by <i>Pseudomonas putida</i> via metabolic engineering and bioprocess developmentAllison Z Werner, William T Cordell, Ciaran W Lahive, et al.
Pageof 51